Lexaria Bioscience Corp (LEXX)
3.46
+0.37
(+11.97%)
USD |
NASDAQ |
May 01, 13:42
Lexaria Bioscience Special Income and Charges (Quarterly)
Special Income and Charges (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Special Income and Charges (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2021 | -- |
| May 31, 2021 | -- |
| February 28, 2021 | -- |
| November 30, 2020 | -- |
| August 31, 2020 | -- |
| May 31, 2020 | -- |
| February 29, 2020 | -- |
| November 30, 2019 | -- |
| August 31, 2019 | -- |
| May 31, 2019 | -- |
| February 28, 2019 | -- |
| November 30, 2018 | -- |
| August 31, 2018 | -- |
| May 31, 2018 | -- |
| February 28, 2018 | -- |
| November 30, 2017 | -- |
| August 31, 2017 | -- |
| May 31, 2017 | -- |
| February 28, 2017 | -- |
| November 30, 2016 | -- |
| August 31, 2016 | -- |
| May 31, 2016 | -- |
| February 29, 2016 | -- |
| November 30, 2015 | -- |
| August 31, 2015 | -- |
| Date | Value |
|---|---|
| May 31, 2015 | -- |
| February 28, 2015 | -- |
| November 30, 2014 | -- |
| July 31, 2014 | -- |
| April 30, 2014 | -- |
| January 31, 2014 | -- |
| October 31, 2013 | -- |
| July 31, 2013 | -- |
| April 30, 2013 | -- |
| January 31, 2013 | -- |
| October 31, 2012 | -- |
| July 31, 2012 | -- |
| April 30, 2012 | -- |
| January 31, 2012 | -- |
| October 31, 2011 | -- |
| July 31, 2011 | -- |
| April 30, 2011 | -- |
| January 31, 2011 | -- |
| October 31, 2010 | -- |
| July 31, 2010 | -- |
| April 30, 2010 | -- |
| January 31, 2010 | -- |
| October 31, 2009 | -- |
| July 31, 2009 | -- |
| April 30, 2009 | -- |
Special Income and Charges Definition
Special Income and Charges refer to gains or losses that are unusual, infrequent, or non-recurring in nature. These items are distinct from the company's core operating activities and are separated from the main operating income to provide transparency regarding the income of these exceptional events on the company's financial performance. Special Income or Charges is calculated by combining several line items from a company's income statement.